Toddlers with anasarca and severe anemia: a lesson in preventive medicine

Jennifer L Salstrom1, Michael Kent, Xiayuan Liang

  • 1Department of Pediatric Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado School of Medicine, Aurora, Colorado, USA.

Insights

Severe iron deficiency anemia in toddlers can cause protein-losing enteropathy, leading to severe swelling. Early detection and treatment by primary care providers are crucial for preventing serious complications.

Area of Science:

  • Pediatrics
  • Hematology
  • Gastroenterology

Background:

  • Iron deficiency anemia (IDA) is a common nutritional deficiency in toddlers.
  • Severe IDA can manifest with systemic complications beyond typical hematological findings.
  • Protein-losing enteropathy (PLE) is a condition characterized by excessive protein loss through the gastrointestinal tract.

Observation:

  • Two toddlers presented with anasarca (generalized edema) and severe anemia.
  • Laboratory results indicated significant iron deficiency, hypoproteinemia, and hypoalbuminemia.
  • Clinical presentation suggested an association between severe IDA and PLE.

Findings:

  • The cases support the hypothesis that severe iron deficiency anemia can lead to protein-losing enteropathy.
  • Literature review indicates a potential pathophysiological link between IDA and gastrointestinal protein leakage.
  • Prompt recognition and management of IDA are essential to resolve associated complications like PLE.

Implications:

  • Highlights the critical role of primary care providers in early diagnosis and preventive medicine for IDA.
  • Underscores the potential for severe, systemic complications of IDA in pediatric populations.
  • Emphasizes the need for timely intervention to prevent irreversible consequences of untreated severe anemia.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...